StockData
QIAGEN N.V. logo

QIAGEN N.V. (QGEN) stock

QGENNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 20, 2026Score 10/30
$49.75−0.06 (-0.12%)

Close on Nov 17, 2026Market cap $10.79BP/E 25.6Yield 0.50%

Qiagen operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

For fiscal 2025 it was $654.33M, down 2.9% from the year before. Over ten years it grew 7.5% a year on average. The highest annual figure on record is $715.26M in fiscal 2022.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$654.33M-2.9%
FY2024Dec 31, 2024$673.55M+46.6%
FY2023Dec 31, 2023$459.46M-35.8%
FY2022Dec 31, 2022$715.26M+11.9%
FY2021Dec 31, 2021$639.00M+39.6%
FY2020Dec 31, 2020$457.81M+38.4%
FY2019Dec 31, 2019$330.84M-8.0%
FY2018Dec 31, 2018$359.50M+25.4%
FY2017Dec 31, 2017$286.78M-16.0%
FY2016Dec 31, 2016$341.60M+7.6%
FY2015Dec 31, 2015$317.50M+10.3%
FY2014Dec 31, 2014$287.97M+11.2%
FY2013Dec 31, 2013$258.96M+5.7%
FY2012Dec 31, 2012$244.88M+0.0%
FY2011Dec 31, 2011$244.78M-2.4%
FY2010Dec 31, 2010$250.75M+15.6%
FY2009Dec 31, 2009$217.00M+25.4%
FY2008Dec 31, 2008$173.00M–

More Qiagen figures

See a number that looks wrong?